Table 2.
Peak laboratory values and outcomes overall and by sex in the CUIMC/NYP COVID-19 cohort.
| Overall (N = 2,626) | Male (N = 1,497) | Female (N = 1,129) | P-value* | |
|---|---|---|---|---|
| Peak labs (median [IQR]) † | ||||
| hs-CRP (mg/L; n = 2,416) | 167.12 (83.80, 281.45) | 185.11 (101.11, 293.01) | 143.99 (65.80, 261.38) | <0.001 |
| D-Dimer (ng/ml; n = 2,180) | 2,565 (1060, 9805) | 2,790 (1060, 12260) | 2,230 (1050, 7463) | 0.0016 |
| Ferritin (ng/ml; n = 2,393) | 931.40 (437.90, 1,934) | 1,184.5 (620.70, 2,269) | 615.5 (295.40, 1,307) | <0.001 |
| Creatinine (mg/dL; n = 2,609) | 1.34 (0.92, 2.71) | 1.49 (1.05, 3.07) | 1.11 (0.80, 2.28) | <0.001 |
| hs-cTnT (ng/L; n = 2,402) | 26 (10, 79) | 29 (11, 84) | 24 (9, 67) | <0.001 |
| Follow-up (30 day) outcomes | ||||
| Ventilator or death | 908/2,626 (0.35) | 555/1,497 (0.37) | 353/1,129 (0.31) | 0.0022 |
| Ventilator‡ | 559/2,626 (0.21) | 365/1,497 (0.24) | 194/1,129 (0.17) | <0.001 |
| Death | 623/2,626 (0.24) | 382/1,497 (0.26) | 241/1,129 (0.21) | 0.0146 |
*
P-values correspond to a two-sample test of proportions (for categorical variables) or Wilcoxon rank sum tests (for numeric variables) comparing corresponding characteristics of male vs. female patients;
†
Peak labs – high sensitivity C-reactive protein (hs-CRP), high sensitivity cardiac Troponin T (hs-cTnT)
‡
349 patients died without being on ventilator.
IQR, interquartile range; hs-CRP, high sensitivity C-reactive protein; hs-cTNT, high sensitivity cardiac Troponin T.